Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 12.19 is 54% above its 5-year average of 7.90, around the middle of its 5-year range (1.23–17.79).
As of the fiscal period ended Tuesday, June 30, 2026. 110.96% above its 12-month average of 5.78.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.19.
QUICK RATIO (ACID-TEST)
12.19
QUICK RATIO (ACID-TEST) AVG TTM
5.78
QUICK RATIO (ACID-TEST) AVG 3Y
7.32
QUICK RATIO (ACID-TEST) AVG 5Y
7.90
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+110.96%
CURRENT VS 3Y AVG
+66.56%
CURRENT VS 5Y AVG
+54.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 853 covered companies
CURRENT VS SECTOR MEDIAN
+263.85%
vs the sector median at left
Opus Genetics, Inc.
Market Cap
$361.23M
Quick Ratio (Acid-Test)
12.19
TTM Avg
5.78
3Y Avg
7.32
5Y Avg
7.90
Market Cap
$356.26M
Quick Ratio (Acid-Test)
1.19
TTM Avg
1.21
3Y Avg
1.62
5Y Avg
1.62
Market Cap
$355.85M
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.18
3Y Avg
1.33
5Y Avg
1.63
Market Cap
$354.08M
Quick Ratio (Acid-Test)
3.76
TTM Avg
4.71
3Y Avg
6.65
5Y Avg
8.92
Market Cap
$354.13M
Quick Ratio (Acid-Test)
5.66
TTM Avg
6.21
3Y Avg
5.34
5Y Avg
8.05
Market Cap
$352.40M
Quick Ratio (Acid-Test)
8.24
TTM Avg
5.34
3Y Avg
5.79
5Y Avg
4.44
Market Cap
$352.98M
Quick Ratio (Acid-Test)
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | $361.23M | 12.19 | 5.78 | 7.32 | 7.90 |
| Embecta Corp. (EMBC)vs › | $361.90M | 1.68 | 1.66 | 1.70 | 1.47 |
| Turn Therapeutics Inc. (TTRX)vs › | $356.26M | 1.19 | 1.21 | 1.62 | 1.62 |
| Ocugen, Inc. (OCGN)vs › | $356.07M | 0.80 | 1.96 | 2.47 | 5.28 |
| Viemed Healthcare, Inc. (VMD)vs › | $355.85M | 1.02 | 1.18 | 1.33 | 1.63 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $354.08M | 3.76 | 4.71 | 6.65 | 8.92 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $354.13M | 5.66 | 6.21 | 5.34 | 8.05 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $352.40M | 8.24 | 5.34 | 5.79 | 4.44 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $352.98M | 24.16 | 12.00 | 8.65 | 7.93 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.27M | 29.52 | 9.54 | 9.83 | 10.59 |
Quick Ratio
12.19
Excludes inventory
Current Ratio
12.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 12.19 |
| 2026-03-31 | 7.13 |
| 2025-12-31 | 6.43 |
| 2025-09-30 | 1.23 |
| 2025-06-30 | 1.90 |
| 2025-03-31 | 1.98 |
| 2024-12-31 | 3.24 |
| 2024-09-30 | 6.63 |
| 2024-06-30 | 10.68 |
| 2024-03-31 | 8.96 |
| 2023-12-31 | 13.35 |
| 2023-09-30 | 13.86 |
| 2023-06-30 | 7.54 |
| 2023-03-31 | 10.93 |
| 2022-12-31 | 17.79 |
| 2022-09-30 | 5.41 |
| 2022-06-30 | 5.41 |
| 2022-03-31 | 6.37 |
| 2021-12-31 | 6.76 |
| 2021-09-30 | 8.79 |
| 2021-06-30 | 9.35 |
| 2021-03-31 | 5.24 |
| 2020-12-31 | 5.55 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
